V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008940 | 190007195 | null | 89.7 | Palliative (P) | 2019-01-20 | 2019-02-06 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101338788 |
| 190009411 | 190007196 | 0 | 45.8 | null | 2018-11-21 | 2019-11-04 | Docetaxel 75mg/m2 (21 day) | 02 | null | METHOTREXATE HIGH DOSE | 101440369 |
| 190010127 | 190007198 | 0 | 62 | Palliative (P) | 2020-07-03 | 2020-07-09 | BEP 5 Day | 02 | N | EW EUROEWING 2012 ARM A VAI | 100767437 |
| 190010137 | 190007199 | 1.5 | 78.9 | null | 2019-04-12 | 2019-08-18 | DOXORUBICIN | N | N | DOXORUBICIN | 100807503 |
| 190000192 | 190007203 | null | null | null | null | 2016-06-01 | null | null | null | MIFAMURTIDE | 100989572 |
| 190000637 | 190007211 | null | null | null | null | 2017-03-23 | null | null | null | MIFAMURTIDE | 100763487 |
| 190000886 | 190007213 | null | null | null | null | 2016-09-06 | null | null | null | MIFAMURTIDE | 101804081 |
| 190001790 | 190007227 | null | null | null | null | 2016-11-17 | null | null | null | MIFAMURTIDE | 101329708 |
| 190001838 | 190007228 | null | null | null | null | 2018-05-29 | null | null | null | MIFAMURTIDE | 100075490 |
| 190002841 | 190007236 | null | null | Curative (C) | null | 2019-10-21 | null | null | null | MIFAMURTIDE | 100697360 |
| 190003334 | 190007242 | null | null | null | null | 2018-09-18 | null | null | null | MIFAMURTIDE | 100796031 |
| 190004865 | 190007258 | null | null | null | null | 2020-09-30 | null | null | null | MIFAMURTIDE | 100282622 |
| 190004909 | 190007261 | null | null | null | null | 2018-01-20 | null | null | null | MIFAMURTIDE | 100303362 |
| 190005046 | 190007270 | null | null | null | null | 2018-10-08 | null | null | null | MIFAMURTIDE | 101731241 |
| 190005517 | 190007289 | null | null | null | null | 2019-03-06 | null | null | null | MIFAMURTIDE | 101739161 |
| 190005676 | 190007296 | null | null | null | null | 2021-12-27 | null | null | null | MIFAMURTIDE | 101632912 |
| 190006572 | 190007335 | null | 73.3 | null | null | 2018-09-05 | null | N | null | MIFAMURTIDE | 101599011 |
| 190006758 | 190007345 | null | null | null | null | 2016-11-13 | null | null | null | MIFAMURTIDE | 100033864 |
| 190006820 | 190007350 | null | 59.3 | null | null | 2017-05-10 | null | 02 | N | MIFAMURTIDE | 101322674 |
| 190007546 | 190007380 | 0 | 11.4 | Curative (C) | 2018-11-12 | 2019-06-03 | DHAP | 01 | N | FLUOROURACIL + IRINOTECAN | 101183946 |
| 190007573 | 190007381 | 1.63 | 92.3 | Curative (C) | 2018-03-21 | 2018-08-26 | Cyclophosphamide + Topotecan | 02 | N | FULVESTRANT + PALBOCICLIB | 100858964 |
| 190007621 | 190007382 | 1.61 | 68.9 | Palliative (P) | null | 2017-12-26 | EW EuroEwing 2012 Arm A VAI | 02 | null | TRIAL UNSPECIFIED | 100261518 |
| 190007623 | 190007383 | 1.77 | 87.1 | Neo-adjuvant (N) | 2018-06-18 | 2018-07-13 | VAI (Ifos 3g/m2) | 02 | N | CISPLATIN + GEMCITABINE | 100179928 |
| 190007635 | 190007384 | 1.78 | 59.7 | Curative (C) | 2017-01-29 | 2017-01-29 | CABOZANTINIB | 02 | null | LANREOTIDE | 100693012 |
| 190007645 | 190007385 | 0 | 36.5 | null | 2016-09-25 | 2016-10-04 | Docetaxel | Y | Y | CARBO + FLUOROURACIL | 100261474 |
| 190007649 | 190007386 | 1.83 | 89 | null | null | 2017-06-06 | Cisplatin + Etoposide po&iv 3 day | null | null | FLUOROURACIL + OXALIPLATIN | 100001004 |
| 190007654 | 190007387 | 1.62 | 66.65 | null | null | 2017-09-02 | EW EuroEwing 2012 Arm A VAI | null | null | TRIAL | 100572959 |
| 190007701 | 190007388 | 0 | 65.8 | Neo-adjuvant (N) | 2020-04-14 | 2020-04-30 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | CISPLATIN + RT | 100415934 |
| 190007716 | 190007389 | 0 | 43.4 | null | null | 2020-03-16 | NIVOLUMAB | 02 | N | BEVACIZUMAB | 101506535 |
| 190007727 | 190007390 | 1.81 | null | Palliative (P) | 2018-10-02 | 2019-01-11 | Cisplatin 7 day | 02 | null | CISPLATIN | 101212824 |
| 190007749 | 190007391 | null | 32.1 | Palliative (P) | 2021-03-31 | 2021-03-31 | null | null | null | CAPECITABINE + CARBOPLATIN | 100048445 |
| 190007755 | 190007392 | 1.74 | 62.3 | null | 2020-08-01 | 2020-12-15 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101408885 |
| 190007780 | 190007393 | 1.27 | 54.3 | Palliative (P) | null | 2018-05-24 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + GEMCITABINE | 101755639 |
| 190007791 | 190007394 | 1.68 | 97.6 | Palliative (P) | 2019-08-13 | 2019-08-18 | Cisplatin + Doxorubicin | 02 | Y | CISPLATIN + EPIRUBICIN | 101649063 |
| 190007793 | 190007395 | 1.64 | null | null | 2019-07-17 | 2019-07-19 | EW EuroEwing 2012 Arm B VDC/IE | null | null | STS NON-RHABDO EPSSG 2005 IE | 101727107 |
| 190007798 | 190007396 | 1.72 | 98.4 | Palliative (P) | null | 2019-09-16 | Bevacizumab 7.5mg/kg | null | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 100064495 |
| 190007826 | 190007397 | 1.65 | 69.3 | Palliative (P) | 2020-01-16 | 2020-02-09 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 100569318 |
| 190007827 | 190007398 | 1.73 | 84.4 | Palliative (P) | 2020-12-14 | 2021-01-08 | Oxaliplatin + Modified de Gramont | 02 | Y | PACLITAXEL | 101706184 |
| 190007852 | 190007399 | 0 | 15.4 | Neo-adjuvant (N) | null | 2017-08-21 | EP | null | null | CAPECITABINE + GEMCITABINE | 101143537 |
| 190007891 | 190007400 | 1.57 | 21.1 | Curative (C) | 2020-10-21 | 2020-11-06 | Docetaxel | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101622902 |
| 190007908 | 190007401 | null | 66.7 | Palliative (P) | 2021-04-08 | 2021-04-28 | Docetaxel 100mg/m2 (21 day) | 01 | N | CARBOPLATIN + ETOPOSIDE | 101778573 |
| 190007914 | 190007402 | 1.37 | 41.8 | Curative (C) | null | 2016-07-08 | Cisplatin + Doxorubicin | null | null | LANREOTIDE | 100957670 |
| 190007921 | 190007403 | 1.63 | 93.4 | Adjuvant (A) | 2021-07-03 | 2021-07-12 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100408763 |
| 190007940 | 190007404 | 1.9 | 58.9 | Palliative (P) | 2017-09-08 | 2017-09-18 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100396252 |
| 190007951 | 190007405 | 0 | 46 | null | null | 2022-04-19 | Cyclophosphamide High Dose | null | null | NIVOLUMAB | 100006144 |
| 190007959 | 190007406 | 0 | 79.1 | Curative (C) | null | 2017-08-22 | Oxaliplatin + Modified de Gramont | null | null | TRIAL UNSPECIFIED | 100937043 |
| 190007962 | 190007407 | 0 | 42.8 | Curative (C) | 2020-05-26 | 2020-12-23 | Docetaxel | 01 | null | FLUOROURACIL + OXALIPLATIN | 101116804 |
| 190007993 | 190007408 | 0 | 27.2 | Palliative (P) | null | 2017-04-20 | DHAP | 02 | N | CETUXIMAB | 100526904 |
| 190008029 | 190007409 | 1.57 | 78.7 | null | 2018-04-30 | 2018-05-04 | Carboplatin 21day + Paclitaxel 7day | null | null | CARBOPLATIN + PACLITAXEL | 100040443 |
| 190008042 | 190007410 | 1.53 | 47.8 | Curative (C) | null | 2020-05-10 | Avelumab | 02 | Y | CAPECITABINE | 101259588 |